Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia
ConditionFanconi Anemia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorNational Cancer Institute (NCI)
About this trial
Background:
Fanconi anemia (FA) is a rare, inherited cancer syndrome. FA causes a range of physical issues. Children with FA may have abnormal features; these may include a small head and eyes and issues with their internal organs. Young adults have a much higher risk of cancer. To screen for these cancers, people with FA may need to pursue many visits with different doctors. This constant need for cancer screening may cause anxiety for people with FA.
Objective:
To learn more about anxiety related to cancer screenings in people with FA.
Eligibility:
Adults aged 18 years and older with FA. They must also be enrolled in FACSS. FACSS is a study that screens people with FA for cancer every year.
Design:
All data gathered for this study will occur during routine FACSS visits. No other visits are needed.
An observer will be in the room during participants FACSS visits. The observer and participant will have a polite introduction. After that, the observer will not interact with participants in any way.
The observer will note details about the participants, such as:
* Body language. * Worries about screening. * Comments that suggest anxiety or depression. * Clinical environment, such as d(SqrRoot)(Copyright)cor and temperature. * Accessibility issues. These can include lights and noises as well as ease of traveling around the clinic center. * Evidence of social support, such as engaging in the FA community. * Challenges they ve had in FACSS. * Their motivation to participate in FACSS. * Relationship dynamics among clinic staff, participants, and their care partners.
Data will also be collected from FACSS visit notes dating back to December 2024 and from participants medical records.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Ability for the participant to speak, read, and/or write in English to understand and agree to a verbal consent.
Participants must have a diagnosis of FA.
Participants must be 18 years of age or older.
Disqualifiers
Individuals who do not meet eligibility criteria.
Subjects who declined or opted out of allowing their data to be used for future research.
Subjects who orally declined to have Dr. Emily Pearce shadow their clinical center visits.
No other exclusionary criteria apply.
Trial population
The study team will conduct a concurrent mixed methods study involving ethnographic data collected from field notes of clinical visits for participants in the Fanconi Anemia Cancer Screening Study (FACSS) protocol (NIH IRB #: 001109), including initial intake and/or return of results.
Trial design
Design model
Case-only
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
20 Participants
are grouped into 1 trial groupGroup A: Participants with a diagnosis of Fanconi anemia
Trial outcomes
Primary outcomes
1
Examine screening-related anxiety usingethnographic field note
This mixed methods study will examine screening-related anxiety using ethnographic field notes include: 1) content analysis of predetermined categories of observation, and 2) qualitative analysis of field notes describing patient provider communication.
Time frame
At Clinical Center VisitSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov